Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?Juan Luis Steegmann, Vicente Escudero‐Vilaplana, Ignacio Gómez‐Centurión et al.|Annals of Hematology|2018Cited by 26